Arca
Skip to content

TriSalus TriNav Advance Infusion System

Catheter, Continuous Flush. 510(k) K253509, from Trisalus Life Sciences (Westminster, CO). Product code KRA, class 2.

As of Nov 17, 2026, K253509 is an FDA 510(k) held by Trisalus Life Sciences, substantially equivalent on Sep 21, 2026 after 320 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Sep 21, 2026
  • Review time: 320 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The TriSalus TriNav Advance Infusion System is intended for use in angiographic procedures. It delivers radiopaque media and therapeutic agents to selected sites in the peripheral vascular system.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other KRA Clearances

The newest 510(k)s for the same product code; their median review was 161 days; see every KRA device

Record

Type
Traditional, third-party review
Received
Nov 5, 2025
Review panel
Cardiovascular
Regulation
21 CFR 870.1210

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.